'We didn't make this medicine for Indians… we made it for western patients who can afford it': Pharmaceutical chief tries to stop India replicating its cancer treatment

  • Indian firm granted government licence to produce copy of a Bayer drug  
  • Nexavar is used for the treatment of kidney, liver and thyroid cancers
  • A patient would pay £58,000 for a year's course of the Bayer version  
  • However the cost of the Natco version would be around £1,700  
  • Bayer CEO Marijn Dekkers made comments during a panel discussion  H
  • e has previously described India's patent laws as 'essentially theft'

Register to read more...